Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Why Is Merck Stock Still An Undervalued Mega-Cap In Pharma?
SHENZHEN, CHINA - JULY 27: In this photo illustration, a smartphone displays the logo of Merck & Co., Inc. (NYSE: MRK), a global pharmaceutical company developing medicines and vaccines, in front of a screen showing the company's latest stock…
Helus Pharma: An Undervalued Psychedelic Platform Approaching A Major Catalyst
Helus Pharma has built a proprietary psychedelic pipeline that currently spans MDD and GAD. The company has two clinical-stage assets and a broader serotonergic discovery platform. Early HLP003 (oral psilocin) and HLP004 (IM DMT) data suggest…
2 Killed, 9 Injured in Reactor Blast At Telangana Pharma Unit
Pochampally: Two workers were killed and nine others injured after a reactor explosion triggered a fire at a pharmaceutical unit in Telangana's Yadadri Bhuvanagiri district late Friday night, police said. The incident occurred at a pharma company…
2 dead, 9 injured in pharma unit explosion in Telangana
2 min read Hyderabad Make us preferred source on Google Two workers were killed and nine others were injured in what police described as a reactor explosion at a pharmaceutical industrial unit in Telangana's Yadadri-Bhuvanagiri district on Friday…
India Pharma Archives launched at IIM-A documenting 125-year industry journey
The Indian Institute of Ahmedabad Archives and Indian Pharmaceutical Alliance on Saturday launched “India Pharma Archives” which is a dedicated digital repository documenting its 125-year evolution of India's pharmaceutical industry.
Kairos Pharma announces 1-for-7 reverse stock split to maintain NYSE compliance
Kairos Pharma () announced on Friday that it will conduct a 1-for-7 reverse stock split effective September 1, 2026, before the market opens. The company's shares will continue trading on the NYSE American under the ticker KAPA. Under the split…
Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset?
The iShares U.S. Pharmaceuticals ETF (IHE +1.01%) offers a lower-cost entry into diversified pharmaceutical leaders, while the Invesco Biotechnology & Genome ETF (PBE +1.07%) targets high-growth biotech and genetic engineering firms. Both funds…
Lantern Pharma (LTRN) Q2 2026 Earnings Call Transcript
Friday, Aug. 14, 2026 at 9:00 a.m. ET President and Chief Executive Officer - Panna Sharma Chief Financial Officer - David R. Margrave Cash, Cash Equivalents, and Marketable Securities -- $7.4 million at June 30, 2026, reflecting the receipt of…
Two killed, 9 injured in a blast at Hazelo Pharma Unit in Telangana
Two workers were killed and nine others were injured in a reactor blast at a pharma company in Yadadri Bhuvanagiri district, Telangana. According to police, the incident occurred late on Friday night in the unit. The incident happened at the Hazelo…
Pharma Co. Loses Challenge To $3M Acne Drug Arb. Award
A New York federal court confirmed an arbitrator's finding that Sun Pharmaceuticals breached an agreement with the owner of an acne drug by seeking regulatory approval to market a version of... To view the full article, register now. Already a…
Wall Street Zen Upgrades Royalty Pharma (NASDAQ:RPRX) to 'Strong-Buy'
Royalty Pharma (NASDAQ:RPRX - Get Free Report) was upgraded by investment analysts at Wall Street Zen from a 'buy' rating to a 'strong-buy' rating in a note issued to investors on Saturday. How Royalty Pharma Prints Cash Without Biotech's Biggest…
Empery Asset Management LP Invests $8.24 Billion in NervGen Pharma $NGEN
Empery Asset Management LP acquired a new stake in NervGen Pharma (NASDAQ:NGEN - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 4,000,000…
Poor-quality medical devices being sold in India, stronger finished-product testing needed, says Pharma Secretary
Too may poor quality medical device products are being made and sold in India and the regulatory system is not able to control all of them, said Department of Pharmaceuticals Secretary Manoj Joshi, calling for stronger testing of finished devices…
Ascentage Pharma Group International (NASDAQ:AAPG) Trading Down 4.9% - Time to Sell?
Shares of Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) were down 4.9% during trading on Friday. The stock traded as low as $17.15 and last traded at $17.15. 307 shares were traded during mid-day trading, a…
Ascentage Pharma Group International's (AAPG) Buy Rating Reaffirmed at BTIG Research
Ascentage Pharma Group International (NASDAQ:AAPG - Get Free Report)'s stock had its 'buy' rating restated by stock analysts at BTIG Research in a research note issued to investors on Friday, Benzinga reports. They presently have a $48.00 price…
Receive a Daily briefing on Pharma Industry News
Get Started